U.S. FDA approves standalone at-home sample collection kit

The U.S. Food and Drug Administration on Saturday approved a standalone at-home sample collection kit for COVID-19 diagnostic testing.

The regulator has given an emergency use authorization (EUA) to Everlywell Inc, a health and wellness company, for its COVID-19 test home collection kit. Everlywell launched the COVID-19 at-home collection kit in March.